<DOC>
	<DOC>NCT00830063</DOC>
	<brief_summary>The purpose of this study is to test the efficacy and safety of 2 doses of tanezumab compared with naproxen and placebo in patients with osteoarthritis.</brief_summary>
	<brief_title>Tanezumab In Osteoarthritis Of The Knee (2)</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Osteoarthritis of the knee according to KellgrenLawrence xray grade of 2 Pregnancy or intent to become pregnant BMI greater than 39 other severe pain, significant cardiac, neurologic or cardiac disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>monoclonal antibody</keyword>
	<keyword>RN624</keyword>
	<keyword>PF-04383119</keyword>
	<keyword>nerve growth factor</keyword>
	<keyword>anti-nerve growth factor</keyword>
	<keyword>OA</keyword>
	<keyword>pain</keyword>
</DOC>